Tom Wilton
Corporate Officer/Principal bij CARISMA THERAPEUTICS, INC.
Actieve functies van Tom Wilton
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-09-2019 | - |
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Loopbaan van Tom Wilton
Opleiding van Tom Wilton
| University of London | Undergraduate Degree |
| University of Leeds | Graduate Degree |
| Brunel University | Graduate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 4 |
| Verenigde Staten | 3 |
Operationeel
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Beurs
- Insiders
- Tom Wilton
- Ervaring